Komori
Daito Pharmaceutical (4577) · RiskMitigated

Disaster and Accident Risk from the Concentration of Production Sites

First written in FY2016. 2 of 5 entries say "Restated". Latest entry: FY2022.

5entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2018WorsenedFY20202016: 120162017: 120172018: 120182019: 020192020: 120202021: 020212022: 12022
Same theme, other companies

The whole theme swung hardest in 2020: 21 of 75 companies on the "Worse" side.

23 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 101 companies compared. The sentences above are computed from all 101.
Full recordFilings, disclosures and news, newest first
  1. FY2022MitigatedAnnual report

    「To address these risks, the Group has organized a Crisis Management Committee to prevent crises in advance and respond promptly when they occur. It has also formulated a business continuity activity plan so that operations can continue even in the event of a major disaster, and is working to continuously improve its ability to respond when disasters occur. In addition, it takes measures such as purchasing various types of insurance, including fire, flood and liability insurance.」

    It specifies measures addressing the risks associated with the concentration of production sites in Toyama Prefecture, natural disasters, infectious diseases and accidents, including the Crisis Management Committee, a business continuity activity plan and insurance coverage.
  2. FY2020WorsenedAnnual report

    「If a major natural disaster or infectious-disease outbreak occurs in Toyama Prefecture, where the Group's production sites are concentrated, or an accident occurs at one of the Group's manufacturing facilities, the Group's business performance and other results may be affected by damage to manufacturing equipment and other assets, suspension of production activities, compensation to business partners and residents living near manufacturing facilities, and other factors.」

    In addition to existing natural-disaster and manufacturing-accident risks, it explicitly identifies infectious-disease outbreaks as a risk associated with the concentration of production sites.
  3. FY2018RestatedAnnual report

    「If a major natural disaster occurs in Toyama Prefecture, where the Group's production sites are concentrated, or an accident occurs at one of the Group's manufacturing facilities, the Group's business performance and other results may be affected by damage to manufacturing equipment and other assets, suspension of production activities, compensation to business partners and residents living near manufacturing facilities, and other factors.」

    Reiterates the natural-disaster and accident risks associated with the concentration of production sites in Toyama Prefecture.
  4. FY2017RestatedAnnual report

    「If a major natural disaster occurs in Toyama Prefecture, where the Group's production sites are concentrated, or an accident occurs at one of the Group's manufacturing facilities, the Group's business performance and other results may be affected by damage to manufacturing equipment and other assets, suspension of production activities, compensation to business partners and residents living near manufacturing facilities, and other factors.」

    Reiterates the natural-disaster and accident risks associated with the concentration of production sites in Toyama Prefecture.
  5. FY2016First statedAnnual report

    「If a major natural disaster occurs in Toyama Prefecture, where the Group's production sites are concentrated, or an accident occurs at one of the Group's manufacturing facilities」

    It assumes impacts from damage to facilities, production stoppages, and compensation paid to business partners and nearby residents.
Moved together

"Economic impact of the spread of COVID-19" moved the same way as this thread, in the same document, in 2 of its 5 moves.

2★1
  1. ★This thread
  2. 1Economic impact of the spread of COVID-192×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Daito Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Disaster and Accident Risk from the Concentration of Production Sites | Daito Pharmaceutical Co.,Ltd. (4577) | Komori